BD Mass Spectrometry Portfolio for Antimicrobial Resistance

Becton Dickinson announced the global distribution of a portfolio of products for mass spectrometry that provides "high-speed and high-confidence" identification of pathogens in clinical laboratories. The firm said that it has completed a comprehensive mass spectrometry solutions suite that includes its MBT Biotargets disposable plates that can be run multiple times, reducing waste, and MBT Sepsityper, a new sepsis management kit.